Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial. (Q51321569)
Jump to navigation
Jump to search
scientific article published on 19 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial. |
scientific article published on 19 June 2014 |
Statements
1 reference
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial. (English)
1 reference
1 reference
Z Punthakee
1 reference
N Alméras
1 reference
J-P Després
1 reference
G R Dagenais
1 reference
S S Anand
1 reference
D L Hunt
1 reference
A M Sharma
1 reference
H Jung
1 reference
S Yusuf
1 reference
19 June 2014
1 reference
1 reference
31
1 reference
9
1 reference
1086-1092
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference